Tag: Novel Coronavirus

Swissmedic authorizes use of BNT162b2 Covid-19 vaccine from Pfizer, BioNTech

pharmanewsdaily- December 20, 2020

Swissmedic, the Swiss Agency for Therapeutic Products, has authorized the use of the BNT162b2 Covid-19 vaccine from US pharma giant Pfizer and German biotech company ... Read More

PRESECO clinical trial for Avigan : Appili begins dosing in phase 3 Covid-19 study

pharmanewsdaily- December 3, 2020

Appili Therapeutics said that it has dosed the first participant in the phase 3 PRESECO clinical trial for Avigan tablets (favipiravir) for the oral treatment ... Read More

UK authorizes Pfizer and BioNTech’s BNT162b2 Covid-19 vaccine

pharmanewsdaily- December 2, 2020

The UK has given a temporary authorization for emergency use for the BNT162b2 Covid-19 vaccine candidate developed by Pfizer and BioNTech. The emergency use authorization ... Read More

Lilly signs $375m deal to supply Covid-19 candidate bamlanivimab to US govt

pharmanewsdaily- October 29, 2020

Eli Lilly and Company (Lilly) has signed a $375 million deal with the US government for the supply of 300,000 vials of bamlanivimab (LY-CoV555) 700mg, ... Read More

AstraZeneca resumes AZD1222 Covid-19 vaccine trials after brief pause

pharmanewsdaily- October 24, 2020

AstraZeneca said that clinical trials for the AZD1222 Covid-19 vaccine candidate, have resumed in various parts of the world after regulators across the US, UK, ... Read More

Covid-19 mRNA vaccine : Precision Nanosystems gets funding boost from Canadian govt

pharmanewsdaily- October 24, 2020

Precision Nanosystems (PNI) has received a funding boost of up to CAD 18.2 million from the Canadian government to develop a mRNA vaccine for Covid-19. ... Read More

Gilead Sciences bags Remdesivir FDA approval for Covid-19 treatment

pharmanewsdaily- October 24, 2020

Remdesivir FDA approval : Gilead Sciences, a California-based biopharma company, has bagged approval from the US Food and Drug Administration (FDA) for its antiviral drug ... Read More

Oxford develops rapid diagnostic test to detect Covid-19 within 5mins

pharmanewsdaily- October 16, 2020

Oxford University claimed that scientists from its Physics department have developed an extremely rapid diagnostic test for Covid-19. The rapid diagnostic test can detect and ... Read More

Novavax begins phase 3 trial of NVX-CoV2373 COVID-19 vaccine candidate

pharmanewsdaily- September 25, 2020

Novavax has initiated its first phase 3 clinical trial to assess the efficacy, safety, and immunogenicity of its NVX-CoV2373 COVID-19 vaccine candidate. The US vaccine ... Read More

J&J begins phase 3 ENSEMBLE Covid-19 vaccine trial for JNJ-78436735

pharmanewsdaily- September 23, 2020

ENSEMBLE Covid-19 vaccine trial : Johnson & Johnson (J&J) has launched a multi-nation phase 3 trial called ENSEMBLE for its JNJ-78436735 Covid-19 vaccine candidate (Ad26.COV2.S), ... Read More